(d) Exhibits 99.1 Press release issued by Celularity Inc. on September 29, 2026. 104 Cover Page Interactive Data File (formatted as Inline XBRL) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its ...
(d) Exhibits 99.1 Press release issued by Celularity Inc. on September 29, 2026. 104 Cover Page Interactive Data File (formatted as Inline XBRL) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its ...
Securities Purchase Agreement On September 23, 2026, Celularity Inc. entered into a Securities Purchase Agreement with the purchasers party thereto , pursuant to which the Company may issue and sell up to an aggregate principal amount of $25.0 million of senior secured convertible promis...
Securities Purchase Agreement On September 23, 2026, Celularity Inc. entered into a Securities Purchase Agreement with the purchasers party thereto , pursuant to which the Company may issue and sell up to an aggregate principal amount of $25.0 million of senior secured convertible promis...
Philip & Daniele Barach Family Trust () reported special transactions (Non-P/S).
Philip & Daniele Barach Family Trust () reported special transactions (Non-P/S).
Barach Philip Alan () reported special transactions (Non-P/S).
Barach Philip Alan () reported special transactions (Non-P/S).
Barach Daniele Wolf () reported special transactions (Non-P/S).
Barach Daniele Wolf () reported special transactions (Non-P/S).
Quant traders caught it because they had backtested systems scanning for this exact pattern.
While others reacted, they execu
https://heyastral.ai/blog/ai-backtesting-edge-systematic-trading-celuw-533-percent-move-2026-07-20-20
Quant traders caught it because they had backtested systems scanning for this exact pattern.
While others reacted, they execu
https://heyastral.ai/blog/ai-backtesting-edge-systematic-trading-celuw-533-percent-move-2026-07-20-20
Discretionary traders read about it after. Quant traders caught it with backtested systems.
The difference? AI-p
https://heyastral.ai/blog/ai-backtesting-edge-systematic-trading-extreme-movers-2026-07-18-20
Discretionary traders read about it after. Quant traders caught it with backtested systems.
The difference? AI-p
https://heyastral.ai/blog/ai-backtesting-edge-systematic-trading-extreme-movers-2026-07-18-20
https://heyastral.ai/blog/ai-backtesting-edge-systematic-trading-extreme-movers-2026-07-18-13
https://heyastral.ai/blog/ai-backtesting-edge-systematic-trading-extreme-movers-2026-07-18-13
#news #StockMarket #investing
https://www.stocktitan.net/news/CELU/celularity-inc-announces-receipt-of-nasdaq-02do4fcxzkrk.html
#news #StockMarket #investing
https://www.stocktitan.net/news/CELU/celularity-inc-announces-receipt-of-nasdaq-02do4fcxzkrk.html
On September 11, 2026, Celularity Inc. received written notifications from the Listing Qualifications Staff of The Nasdaq Stock Market LLC confirming that Celularity has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) and the minimum market...
On September 11, 2026, Celularity Inc. received written notifications from the Listing Qualifications Staff of The Nasdaq Stock Market LLC confirming that Celularity has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) and the minimum market...
Celularity Inc. regained compliance with Nasdaq's minimum bid price and market value of listed securities requirements (Rules 5550(a)(2) and 5550(b)(2)), and both matters are closed.
🧵 continued ↓
Celularity Inc. regained compliance with Nasdaq's minimum bid price and market value of listed securities requirements (Rules 5550(a)(2) and 5550(b)(2)), and both matters are closed.
🧵 continued ↓
No valid summary extracted.
No valid summary extracted.
https://heyastral.ai/blog/ai-backtesting-edge-trade-stocks-celuw-533-percent-move-2026-07-20-13
https://heyastral.ai/blog/ai-backtesting-edge-trade-stocks-celuw-533-percent-move-2026-07-20-13
https://seekingalpha.com/news/4454022-celularity-notified-of-nasdaq-non-compliance?utm_source=feed_news_all&utm;_medium=referral&feed;_item_type=news
#celuw
Result Details
https://seekingalpha.com/news/4454022-celularity-notified-of-nasdaq-non-compliance?utm_source=feed_news_all&utm;_medium=referral&feed;_item_type=news
#celuw
Result Details
On June 29, 2026, Celularity Inc. entered into a Loan Agreement with the Philip & Daniele Barach Family Trust , a trust affiliated with Philip Barach, who is known by the Company to beneficially own more than five percent of the Company’s outstanding Class A common stock.
On June 29, 2026, Celularity Inc. entered into a Loan Agreement with the Philip & Daniele Barach Family Trust , a trust affiliated with Philip Barach, who is known by the Company to beneficially own more than five percent of the Company’s outstanding Class A common stock.
No valid summary extracted.
No valid summary extracted.
Philip & Daniele Barach Family Trust () reported special transactions (Non-P/S).
Philip & Daniele Barach Family Trust () reported special transactions (Non-P/S).
Barach Philip Alan () reported special transactions (Non-P/S).
Barach Philip Alan () reported special transactions (Non-P/S).
Barach Daniele Wolf () reported special transactions (Non-P/S).
Barach Daniele Wolf () reported special transactions (Non-P/S).
On June 9, 2026, Celularity Inc. received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market, LLC notifying the Company that for the last 30 consecutive business days prior to the date of the Notice, the Company’s minimum Market Value of Listed Securities was...
On June 9, 2026, Celularity Inc. received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market, LLC notifying the Company that for the last 30 consecutive business days prior to the date of the Notice, the Company’s minimum Market Value of Listed Securities was...
On June 3, 2026, Celularity issued a press release announcing the appointment of Mr. Gonzalez as Chief Commercial Officer.
On June 3, 2026, Celularity issued a press release announcing the appointment of Mr. Gonzalez as Chief Commercial Officer.
As previously disclosed by Celularity Inc. in its Current Report on Form 8-K filed on April 21, 2026, Helena Global Investment Opportunities 1 Ltd. delivered an exchange notice pursuant to which Helena elected to exchange shares of the Company’s Series A Convertible Preferred Stock for a...
As previously disclosed by Celularity Inc. in its Current Report on Form 8-K filed on April 21, 2026, Helena Global Investment Opportunities 1 Ltd. delivered an exchange notice pursuant to which Helena elected to exchange shares of the Company’s Series A Convertible Preferred Stock for a...